Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
CRM -6.69NOA.TO 0.01U.UN.TO -0.08BLX -0.19ELF.TO -0.23RY.TO 1.72PEY.TO -0.29CP.TO -3.89
Daily Stock Opinions and Ratings
Stockchase Opinions

Hugh Cleland, CFATrillium Therapeutics IncTRIL.TOWATCHMar 31, 2008

Fascinated by the technology, they’re taking 2 off patent drugs and combining them to use in therapy for stroke victims. Has a lot of potential. Still has some huge upside.
Hugh Cleland, CFAHugh Cleland, CFA
Owned
Unlock Rating
$0.24

Stock price when the opinion was issued

$23.33

As of Nov 19, 2021. Market Open.

Consumer Products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

COMMENT

Trillium Therapeutics Inc(TRIL.TO)

Aug 23, 2021

Pfizer bought it today, and TRIL shares tripled from $6 to $18 in the blink of an eye. That's why he always advises investing in small drug companies; sometimes they pan out.

Photo of Jim Cramer - Mad MoneyJim Cramer - Mad MoneyUnlock Rating
$22.22

Stock price when the opinion was issued

$23.33

As of Nov 19, 2021. Market Open.

Consumer Products
HOLD

Trillium Therapeutics Inc(TRIL.TO)

Nov 13, 2009
(Market Call Minute.) Volatile stock and you can hold it if it hangs in there but be careful.
Photo of Paul ThorntonPaul ThorntonUnlock Rating
$0.16

Stock price when the opinion was issued

$23.33

As of Nov 19, 2021. Market Open.

Consumer Products
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

SAN -0.05$13.33
MS 4.13$224.96
GS 8.47$1099.14
COF 0.25$200.87
INGR -1.97$98.84

Today's Top Picks

CRM -6.69$155.02
NOA.TO 0.01$18.92
U.UN.TO -0.08$26.76
BLX -0.19$59.05
ELF.TO -0.23$16.75

Popular Articles

Latest Sell Signals

SYK -9.44$301.14
FICO -59.4$1126.84
BBD.B.TO -6.39$303.18
MTL.TO -1.12$21.34
BN.TO -0.73$63.22

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

John Zechner

John Zechner

J. Zechner & Assoc

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Keith Richards

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Joe Terranova

Virtus Investment Partners

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica